Biblio

Export 549 results:
Author Title [ Type(Asc)] Year
Filters: Keyword is Alzheimer Disease  [Clear All Filters]
Journal Article
H. Y. H. Hui, Ran, A. Ran, Dai, J. Jia, and Cheung, C. Y., Deep Reinforcement Learning-Based Retinal Imaging in Alzheimer's Disease: Potential and Perspectives., J Alzheimers Dis, vol. 94, no. 1, pp. 39-50, 2023.
D. W. Scharre, Weichart, E., Nielson, D., Zhang, J., Agrawal, P., Sederberg, P. B., Knopp, M. V., and Rezai, A. R., Deep Brain Stimulation of Frontal Lobe Networks to Treat Alzheimer's Disease., J Alzheimers Dis, vol. 62, no. 2, pp. 621-633, 2018.
J. A. Matías-Guiu, Pytel, V., and Matías-Guiu, J., Death Rate Due to COVID-19 in Alzheimer's Disease and Frontotemporal Dementia., J Alzheimers Dis, vol. 78, no. 2, pp. 537-541, 2020.
M. Pacheco-Herrero, Soto-Rojas, L. O., Reyes-Sabater, H., Garcés-Ramirez, L., López, Fde la Cruz, Villanueva-Fierro, I., and Luna-Muñoz, J., Current Status and Challenges of Stem Cell Treatment for Alzheimer's Disease., J Alzheimers Dis, vol. 84, no. 3, pp. 917-935, 2021.
L. GjØra, Strand, B. Heine, Bergh, S., Borza, T., Brækhus, A., Engedal, K., Johannessen, A., Kvello-Alme, M., Krokstad, S., Livingston, G., Matthews, F. E., Myrstad, C., Skjellegrind, H., Thingstad, P., Aakhus, E., Aam, S., and Selbæk, G., Current and Future Prevalence Estimates of Mild Cognitive Impairment, Dementia, and Its Subtypes in a Population-Based Sample of People 70 Years and Older in Norway: The HUNT Study., J Alzheimers Dis, vol. 79, no. 3, pp. 1213-1226, 2021.
M. Golzari-Sorkheh, Weaver, D. F., and Reed, M. A., COVID-19 as a Risk Factor for Alzheimer's Disease., J Alzheimers Dis, vol. 91, no. 1, pp. 1-23, 2023.
O. Turró-Garriga, Garre-Olmo, J., Calvó-Perxas, L., Reñé-Ramírez, R., Gascón-Bayarri, J., and Conde-Sala, J. Lluís, Course and Determinants of Anosognosia in Alzheimer's Disease: A 12-Month Follow-up., J Alzheimers Dis, vol. 51, no. 2, pp. 357-66, 2016.
R. R. Romano, Carter, M. A., Dietrich, M. S., Cowan, R. L., Bruehl, S. P., and Monroe, T. B., Could Altered Evoked Pain Responsiveness Be a Phenotypic Biomarker for Alzheimer's Disease Risk? A Cross-Sectional Analysis of Cognitively Healthy Individuals., J Alzheimers Dis, vol. 79, no. 3, pp. 1227-1233, 2021.
H. - L. Sun, Zhou, F. - Y., Chen, D. - W., Tan, C. - R., Zeng, G. - H., Liu, Y. - H., Wang, J., Le Bu, X. -, Wang, Y. - J., Li, H. - Y., and Jin, W. - S., The Correlation of Tau Levels with Blood Monocyte Count in Patients with Alzheimer's Disease., J Alzheimers Dis, vol. 85, no. 3, pp. 1321-1328, 2022.
M. Pievani, Pini, L., Ferrari, C., Pizzini, F. B., Galazzo, I. Boscolo, Cobelli, C., Cotelli, M., Manenti, R., and Frisoni, G. B., Coordinate-Based Meta-Analysis of the Default Mode and Salience Network for Target Identification in Non-Invasive Brain Stimulation of Alzheimer's Disease and Behavioral Variant Frontotemporal Dementia Networks., J Alzheimers Dis, vol. 57, no. 3, pp. 825-843, 2017.
A. Mahzarnia, Lutz, M. W., and Badea, A., A Continuous Extension of Gene Set Enrichment Analysis Using the Likelihood Ratio Test Statistics Identifies Vascular Endothelial Growth Factor as a Candidate Pathway for Alzheimer's Disease via ITGA5., J Alzheimers Dis, vol. 97, no. 2, pp. 635-648, 2024.
J. D. Doecke, Rembach, A., Villemagne, V. L., Varghese, S., Rainey-Smith, S., Sarros, S., Evered, L. A., Fowler, C. J., Pertile, K. K., Rumble, R. L., Trounson, B., Taddei, K., Laws, S. M., S Macaulay, L., Bush, A. I., Ellis, K. A., Martins, R., Ames, D., Silbert, B., Vanderstichele, H., Masters, C. L., Darby, D. G., Li, Q. - X., and Collins, S., Concordance Between Cerebrospinal Fluid Biomarkers with Alzheimer's Disease Pathology Between Three Independent Assay Platforms., J Alzheimers Dis, vol. 61, no. 1, pp. 169-183, 2018.
X. Sun, Ma, R., Yao, X., Shang, X., Wang, Q., Wang, J. - Z., and Liu, G., Concanavalin agglutinin levels are decreased in peripheral blood of Alzheimer's disease patients., J Alzheimers Dis, vol. 49, no. 1, pp. 63-72, 2016.
F. Oluwasegun Ishabiyi, Ogidi, J. Okwudirich, Olukade, B. Adejoke, Amorha, C. Christabel, El-Sharkawy, L. Y., Okolo, C. Calistus, Adeniyi, T. Mary, Atasie, N. Hope, Ibrahim, A., and Balogun, T. Adewale, Computational Evaluation of Azadirachta indica-Derived Bioactive Compounds as Potential Inhibitors of NLRP3 in the Treatment of Alzheimer's Disease., J Alzheimers Dis, vol. 94, no. s1, pp. S67-S85, 2023.
A. Medoro, Bartollino, S., Mignogna, D., Passarella, D., Porcile, C., Pagano, A., Florio, T., Nizzari, M., Guerra, G., Di Marco, R., Intrieri, M., Raimo, G., and Russo, C., Complexity and Selectivity of γ-Secretase Cleavage on Multiple Substrates: Consequences in Alzheimer's Disease and Cancer., J Alzheimers Dis, vol. 61, no. 1, pp. 1-15, 2018.
E. Racine, Forlini, C., Aspler, J., and Chandler, J., Complementary and Alternative Medicine in the Context of Earlier Diagnoses of Alzheimer's Disease: Opening the Conversation to Prepare Ethical Responses., J Alzheimers Dis, vol. 51, no. 1, pp. 1-9, 2016.
P. N. Tariot, Braeckman, R., and Oh, C., Comparison of Steady-State Pharmacokinetics of Donepezil Transdermal Delivery System with Oral Donepezil., J Alzheimers Dis, vol. 90, no. 1, pp. 161-172, 2022.
S. Wong, Bertoux, M., Savage, G., Hodges, J. R., Piguet, O., and Hornberger, M., Comparison of Prefrontal Atrophy and Episodic Memory Performance in Dysexecutive Alzheimer's Disease and Behavioral-Variant Frontotemporal Dementia., J Alzheimers Dis, vol. 51, no. 3, pp. 889-903, 2016.
N. Altomari, Bruno, F., Laganà, V., Smirne, N., Colao, R., Curcio, S., Di Lorenzo, R., Frangipane, F., Maletta, R., Puccio, G., and Bruni, A. Cecilia, A Comparison of Behavioral and Psychological Symptoms of Dementia (BPSD) and BPSD Sub-Syndromes in Early-Onset and Late-Onset Alzheimer's Disease., J Alzheimers Dis, vol. 85, no. 2, pp. 691-699, 2022.
J. A. Matías-Guiu, Cabrera-Martín, M. Nieves, Curiel, R. E., Valles-Salgado, M., Rognoni, T., Moreno-Ramos, T., Carreras, J. Luis, Loewenstein, D. A., and Matías-Guiu, J., Comparison between FCSRT and LASSI-L to Detect Early Stage Alzheimer's Disease., J Alzheimers Dis, vol. 61, no. 1, pp. 103-111, 2018.
Y. Yamada, Shinkawa, K., Kobayashi, M., Caggiano, V., Nemoto, M., Nemoto, K., and Arai, T., Combining Multimodal Behavioral Data of Gait, Speech, and Drawing for Classification of Alzheimer's Disease and Mild Cognitive Impairment., J Alzheimers Dis, vol. 84, no. 1, pp. 315-327, 2021.
A. Dodich, Cerami, C., Cappa, S. F., Marcone, A., Golzi, V., Zamboni, M., Giusti, M. Cristina, and Iannaccone, S., Combined Socio-Behavioral Evaluation Improves the Differential Diagnosis Between the Behavioral Variant of Frontotemporal Dementia and Alzheimer's Disease: In Search of Neuropsychological Markers., J Alzheimers Dis, vol. 61, no. 2, pp. 761-772, 2018.
K. Hensley and Kursula, P., Collapsin Response Mediator Protein-2 (CRMP2) is a Plausible Etiological Factor and Potential Therapeutic Target in Alzheimer's Disease: Comparison and Contrast with Microtubule-Associated Protein Tau., J Alzheimers Dis, vol. 53, no. 1, pp. 1-14, 2016.
C. E. Gleason, Norton, D., Anderson, E. D., Wahoske, M., Washington, D. T., Umucu, E., Koscik, R. L., N Dowling, M., Johnson, S. C., Carlsson, C. M., and Asthana, S., Cognitive Variability Predicts Incident Alzheimer's Disease and Mild Cognitive Impairment Comparable to a Cerebrospinal Fluid Biomarker., J Alzheimers Dis, vol. 61, no. 1, pp. 79-89, 2018.
Y. Stern, Cognitive reserve in ageing and Alzheimer's disease., Lancet Neurol, vol. 11, no. 11, pp. 1006-12, 2012.

Pages